Key Figures Q2 2008

Key Figures provide a succinct overview of the most significant developments for each period under review. You can view earlier quarters or years if you wish. Furthermore, you can find extensive reports by downloading press releases for the period of your choice.

• Very strong Q2 result based on 17% organic sales growth
• Changing dynamics in vitamin business drive significantly higher profitability in Life Sciences.
• Materials Sciences performing well against difficult economic background.
• EBIT from continuing operations up 19% to EUR 276 million.
• Earnings per share 34% higher.
• Guidance raised: 2008 EBIT from continuing operations expected to be around EUR 970 million, with potential upside.
• Execution of Vision 2010 strategy fully on track